OGN vs SDGR · P/E 3.4, rev $6.40B vs rev $255.9M
Organon & Co (OGN) versus Schrodinger Inc (SDGR) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Schrodinger Inc (SDGR) is a health information services company listed on NASDAQ.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported SDGR revenue for 2025-12-31 was $255.9M. Net income was -$103.3M. Revenue was up 23.3% from 2024-12-31 to 2025-12-31. SDGR currently screens at market cap $1.16B.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. SDGR currently screens at market cap $1.16B.
Not investment advice. Open the OGN and SDGR stock pages for the full models.
Not investment advice.